Theravance Biopharma, Inc.TBPHNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank36
3Y CAGR-41.2%
5Y CAGR-31.4%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-41.2%/yr
vs -11.7%/yr prior
5Y CAGR
-31.4%/yr
Recent deceleration
Acceleration
-29.5pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.30M | -49.1% |
| 2024 | $2.55M | +8.3% |
| 2023 | $2.35M | -63.1% |
| 2022 | $6.37M | -25.5% |
| 2021 | $8.55M | 0.0% |
| 2020 | $8.55M | -73.2% |
| 2019 | $31.86M | +204.0% |
| 2018 | $10.48M | +22.6% |
| 2017 | $8.55M | +508.8% |
| 2016 | $1.40M | - |